Insulet (PODD) Share-based Compensation (2010 - 2026)
Insulet (PODD) posted Share-based Compensation of $15.7 million for Q1 2026, up 1862.5% on a QoQ basis from $800000.0 in Q4 2025, and down 25.94% year-over-year from $21.2 million in Q1 2025.
Insulet (PODD) Share-based Compensation (2010 - 2026) Analysis & Trends
Insulet's Share-based Compensation history runs 17 years deep, the most recent figure standing at $15.7 million for Q1 2026.
- Quarterly Share-based Compensation fell 25.94% year-over-year to $15.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.4 million (down 76.14% YoY) and the FY2025 annual result came in at $25.9 million, down 62.63% from the prior year.
- Share-based Compensation was $15.7 million for Q1 2026 at Insulet, up from $800000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $69.0 million in Q4 2024 and bottomed at -$30.9 million in Q3 2024.
- A 5-year average of $9.7 million and a median of $9.0 million in 2022 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2023 — Share-based Compensation sank 300.89% — and 2024, when it soared 1646.67%.
- Insulet's Share-based Compensation stood at $11.2 million in 2022, then sank by 300.89% to -$22.5 million in 2023, then soared by 406.67% to $69.0 million in 2024, then tumbled by 98.84% to $800000.0 in 2025, then soared by 1862.5% to $15.7 million in 2026.
- Business Quant data shows PODD's Share-based Compensation at $15.7 million in Q1 2026, $800000.0 in Q4 2025, and $2.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.52 Bn | 175.22 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 128.96 Bn | 126.09 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 67.76 Bn | 66.31 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 48.09 Bn | 44.41 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 35.80 Mn |
| 7 | GE HealthCare Technologies | 27.89 Bn | 25.61 Bn | 1.98 Bn | 35.00 Mn |
| 8 | Smith & Nephew | 27.02 Bn | 26.45 Bn | - | - |
| 9 | Koninklijke Philips | 23.98 Bn | 20.86 Bn | 2.07 Bn | 35.12 Mn |
| 10 | Insulet | 11.56 Bn | 11.07 Bn | 529.10 Mn | 15.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.70 Mn |
| Mar 31, 2026 | 15.70 Mn |
| Dec 31, 2025 | 800,000.00 |
| Dec 31, 2025 | 800,000.00 |
| Sep 30, 2025 | 2.20 Mn |
| Sep 30, 2025 | 2.20 Mn |
| Jun 30, 2025 | 1.70 Mn |
| Jun 30, 2025 | 1.70 Mn |
| Mar 31, 2025 | 21.20 Mn |
| Mar 31, 2025 | 21.20 Mn |
| Dec 31, 2024 | 69.00 Mn |
| Dec 31, 2024 | 69.00 Mn |
| Sep 30, 2024 | -30.90 Mn |
| Sep 30, 2024 | -30.90 Mn |
| Jun 30, 2024 | 26.20 Mn |
| Jun 30, 2024 | 26.20 Mn |
| Mar 31, 2024 | 5.00 Mn |
| Mar 31, 2024 | 5.00 Mn |
| Dec 31, 2023 | -22.50 Mn |
| Dec 31, 2023 | -22.50 Mn |